INCOME STATEMENT (Quarterly GAAP In millions $) |
(Sep 30 2023) III. Quarter |
(Jun 30 2023) II. Quarter |
(Mar 31 2023) I. Quarter |
(Dec 31 2022) IV. Quarter |
(Sep 30 2022) III. Quarter |
Revenue From Contract With Customer Including Assessed Tax |
68.69 |
- |
- |
|
- |
Other Revenue |
-0.20 |
- |
- |
|
- |
Total Revenue |
68.49 |
0.00 |
0.00 |
151.69 |
0.00 |
Cost of Goods and Services Sold |
68.00 |
- |
- |
156.08 |
- |
Gross
Profit |
0.49 |
0.00 |
0.00 |
-4.40 |
0.00 |
Selling, Administration, Marketing |
8.99 |
- |
- |
-17.85 |
- |
Depriciation & Amortization |
- |
- |
- |
1.83 |
- |
Research and Development Expense |
0.04 |
- |
- |
-0.14 |
- |
Accretion Expense |
7.74 |
- |
- |
1.40 |
- |
Other operatinig exp. /-income |
-7.74 |
- |
- |
30.55 |
- |
Unusual Expense /-Income |
- |
- |
- |
- |
- |
Gain On Debt Extinguishment Portions |
- |
- |
- |
0.00 |
- |
Accretion And Other Expenses Of Series A Preferred Units |
- |
- |
- |
2.19 |
- |
Total operating costs including COS |
77.02 |
- |
- |
174.07 |
- |
Operating income/-loss
|
-8.53 |
- |
- |
-22.38 |
- |
Other Deductions / - Income |
Interest expense |
- |
- |
- |
8.94 |
- |
Interest Expense, Borrowings |
-8.75 |
- |
- |
21.41 |
- |
Interest income |
- |
- |
- |
- |
- |
Net interest expense/-income |
-8.75 |
- |
- |
30.34 |
- |
Extinguishment of Debt |
- |
- |
- |
49.39 |
- |
Loss/ -Gain on Investment |
- |
- |
- |
- |
- |
Foreign Currency Transaction (Gain) Loss |
- |
- |
- |
- |
- |
Allowances, Health Care Trust Fund And Other |
- |
- |
- |
- |
- |
Business Combination, Bargain Purchase, Gain Recognized, Amount |
- |
- |
- |
- |
- |
Other loss/ -income |
24.82 |
- |
- |
-23.56 |
- |
Total costs & expenses |
93.09 |
0.00 |
0.00 |
230.24 |
0.00 |
Income /-loss before income taxes |
-24.60 |
0.00 |
0.00 |
-78.55 |
0.00 |
Income taxes expenses/-benefit |
-55.31 |
- |
- |
1.05 |
- |
Income after income taxes |
30.71 |
0.00 |
0.00 |
-79.60 |
0.00 |
Net income/-loss
of other equity |
- |
- |
- |
- |
- |
Income/-loss
from cont. Ops. |
30.71 |
0.00 |
0.00 |
-79.60 |
0.00 |
Accounting change |
- |
- |
- |
- |
- |
Discontinued operations |
- |
- |
- |
- |
- |
Extraordinary items |
- |
- |
- |
- |
- |
Net Income/-loss |
30.71 |
0.00 |
0.00 |
-79.60 |
0.00 |
Noncontrolling interests |
- |
- |
- |
- |
- |
Prefered dividends |
- |
- |
- |
- |
- |
Other |
- |
- |
- |
- |
- |
Income/-loss to shareholder |
30.71 |
0.00 |
0.00 |
-79.60 |
0.00 |
EBIT |
-33.35 |
0.00 |
0.00 |
-48.21 |
0.00 |
EBITD |
-31.60 |
1.67 |
1.79 |
-46.71 |
0.00 |
EBITDA |
-30.14 |
3.00 |
3.77 |
-44.54 |
1.27 |